Developmental toxicity: artificial intelligence-powered assessments
- PMID: 40374415
- PMCID: PMC12145233
- DOI: 10.1016/j.tips.2025.04.005
Developmental toxicity: artificial intelligence-powered assessments
Abstract
Regulatory agencies require comprehensive toxicity testing for prenatal drug exposure, including new drugs in development, to reduce concerns about developmental toxicity, that is, drug-induced toxicity and adverse effects in pregnant women and fetuses. However, defining developmental toxicity endpoints and optimal analysis of associated public big data remain challenging. Recently, artificial intelligence (AI) approaches have had a critical role in analyzing complex, high-dimensional data, uncovering subtle relationships between chemical exposures and associated developmental risks. Here, we present an overview of major big data resources and data-driven models that focus on predicting various toxicity endpoints. We also highlight emerging, interpretable AI models that integrate multimodal data and domain knowledge to reveal toxic mechanisms underlying complex endpoints, and outline a potential framework that leverages multiple interpretable models to comprehensively evaluate chemical-induced developmental toxicity.
Keywords: artificial intelligence; computational toxicology; developmental toxicity; interpretable modeling; multimodal data.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests None declared by authors.
References
-
- Dude C and Jamieson DJ (2021) Assessment of the safety of common medications used during pregnancy. JAMA 326, 2421–2422 - PubMed
-
- Rogers JM and Kavlock RJ (1998) Developmental toxicology. In Reproductive and Developmental Toxicology, pp. 65–90, CRC Press
Resources
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical